Oxford Global, Hyatt Regency Boston, One Avenue de Lafayette, Boston, Massachusetts, United States, 02111
07 - 08 April 2020
350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis & Genome Editing. 80+ case studies, solution & technology presentations & 2 interactive workshops. View Agenda: http://bit.ly/2Ophy8b 07 April 2019 – Day One - Single Cell ‘Omics Analysis: Current And Emerging Tools, parallel sequencing of single-cell genomes and transcriptomes and Spatial Transcriptomics
- Single Cell in Clinical Use – Applications in the clinic & Diagnostic Development
08 April 2019 – Day Two - Interactive Workshop: Spatial Transcriptomics
- Single-Cell Analysis In Drug Discovery and Development including immune-repertoire profiling
- Overcoming Challenges- Benchmarking study on scRNA-seq technologies, sample prep and multi-omic bioinformatics solutions
|
|
|
Invited Speakers:
|
|
Brian Dougherty, Executive Director of Translational Medicine, AstraZeneca Bin Li, Director, Computational Biology, Takeda Jin Jen, Director, Sequencing Research, Celgene Shanrong Zhao, Director, Pfizer Wade Davis, Director Computational Genomics, Genomics Research Center (GRC), AbbVie Esperanza Anguiano, Associate Director, Clinical Genetics and Genomics, Translational Medicine, Bristol-Myers Squibb Company
|
|